158 related articles for article (PubMed ID: 36617473)
1. [Review for N2 Sub-staging in Non-small Cell Lung Cancer].
Bao Y; Hui Z
Zhongguo Fei Ai Za Zhi; 2022 Dec; 25(12):870-876. PubMed ID: 36617473
[TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
[TBL] [Abstract][Full Text] [Related]
3. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
Asamura H; Chansky K; Crowley J; Goldstraw P; Rusch VW; Vansteenkiste JF; Watanabe H; Wu YL; Zielinski M; Ball D; Rami-Porta R;
J Thorac Oncol; 2015 Dec; 10(12):1675-84. PubMed ID: 26709477
[TBL] [Abstract][Full Text] [Related]
4. N2 lung cancer is not all the same: an analysis of different prognostic groups.
Bertoglio P; Ricciardi S; Alì G; Aprile V; Korasidis S; Palmiero G; Fontanini G; Mussi A; Lucchi M
Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):720-726. PubMed ID: 29788107
[TBL] [Abstract][Full Text] [Related]
5. Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study.
Park BJ; Kim TH; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Cho JH
J Thorac Oncol; 2019 Nov; 14(11):1962-1969. PubMed ID: 31442497
[TBL] [Abstract][Full Text] [Related]
6. External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.
Chiappetta M; Lococo F; Leuzzi G; Sperduti I; Petracca-Ciavarella L; Bria E; Mucilli F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F; Margaritora S
Eur J Cardiothorac Surg; 2020 Dec; 58(6):1236-1244. PubMed ID: 32770184
[TBL] [Abstract][Full Text] [Related]
7. Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis.
Wang S; Xie S; Han Y; Gao M; Su X; Liu Q
BMC Pulm Med; 2023 Apr; 23(1):147. PubMed ID: 37118722
[TBL] [Abstract][Full Text] [Related]
8. Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer.
Li S; Yan S; Lu F; Lv C; Wang Y; Li X; Wang Y; Yang Y; Wu N
Ann Surg Oncol; 2021 Aug; 28(8):4510-4516. PubMed ID: 33389296
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.
Chen W; Zhang C; Wang G; Yu Z; Liu H
Thorac Cancer; 2019 Jul; 10(7):1533-1543. PubMed ID: 31207184
[TBL] [Abstract][Full Text] [Related]
10. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery.
Tsitsias T; Okiror L; Veres L; King J; Harrison-Phipps K; Routledge T; Pilling J; Bille A
Lung Cancer; 2021 Jan; 151():84-90. PubMed ID: 33250210
[TBL] [Abstract][Full Text] [Related]
11. [Results of N1 and N2 surgery in non-small cell lung cancer].
Pfannschmidt J; Kollmeier J
Chirurg; 2019 Dec; 90(12):974-981. PubMed ID: 31501934
[TBL] [Abstract][Full Text] [Related]
12. Does anatomical location-based metastatic lymph node density affect prognosis in lung cancer patients?
Aksoy Y; Çıtak N; Obuz Ç; Metin M; Sayar A
Interact Cardiovasc Thorac Surg; 2021 Oct; 33(4):541-549. PubMed ID: 34000035
[TBL] [Abstract][Full Text] [Related]
13. New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer.
Hattori A; Takamochi K; Oh S; Suzuki K
Jpn J Clin Oncol; 2019 Jan; 49(1):3-11. PubMed ID: 30277521
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
[TBL] [Abstract][Full Text] [Related]
15. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of the number of involved lymph node stations in patients with completely resected non-small cell lung cancer: a proposal for future revisions of the N classification.
Kojima H; Terada Y; Yasuura Y; Konno H; Mizuno T; Isaka M; Funai K; Ohde Y
Gen Thorac Cardiovasc Surg; 2020 Nov; 68(11):1298-1304. PubMed ID: 32449108
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
[TBL] [Abstract][Full Text] [Related]
18. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
19. Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.
Lee JG; Lee CY; Bae MK; Park IK; Kim DJ; Kim KD; Chung KY
J Thorac Oncol; 2008 Dec; 3(12):1421-6. PubMed ID: 19057267
[TBL] [Abstract][Full Text] [Related]
20. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
